The novel atypical retinoid ST1926 is active in ATRA resistant neuroblastoma cells acting by a different mechanism

Single cell gel/comet assay: Guidelines for in vitro and in vivo genetic toxicology testing

Raymond R. Tice, Eva Agurell, Diana Anderson et al. · Environmental and Molecular Mutagenesis · 2000 · 4.8K citations

Pharmacy, Genetics, Toxicology +17

Treatment of High-Risk Neuroblastoma with Intensive Chemotherapy, Radiotherapy, Autologous Bone Marrow Transplantation, and 13-<i>cis</i>-Retinoic Acid

Katherine K. Matthay, Judith G. Villablanca, Robert C. Seeger et al. · New England Journal of Medicine · 1999 · 1.9K citations · Full text

Medicine, Oncology, Pharmacology +7

Identification of synthetic retinoids with selectivity for human nuclear retinoic acid receptor γ

Bruno Bernard, Jean‐Michel Bernardon, C. Delescluse et al. · Biochemical and Biophysical Research Communications · 1992 · 207 citations

Life Sciences, Medicinal Chemistry, Molecular Biology +9

Evidence for the development of p53 mutations after cytotoxic therapy in a neuroblastoma cell line.

Deborah A. Tweddle, Archie J. Malcolm, N Bown et al. · PubMed · 2001 · 178 citations

Medicine, Molecular Genetics, Oncology +16

Selective high affinity retinoic acid receptor alpha or beta-gamma ligands.

C. Delescluse, M.T. Cavey, Bernard Martin et al. · PubMed · 1991 · 145 citations

Life Sciences, Genetics, Molecular Biology +14